human coagulation factor ix (Mononine) Report issue

Biologics Recombinant protein Orphan Drug FDA Approved FDA
AACT ChEMBL DrugBank MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Factor IX is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes haemophilia B. It was discovered in 1952 after a young boy named Stephen Christmas was found to be lacking this exact factor, leading to haemophilia.   Wikipedia

Chemistry

More Chemistry

Pharmacology

Alternative names

4f-pcc | alphanine | alphanine sd | antihemophilic factor | antihemophilic factor/von willebrand factor complex (human) | coagulation factor ix | coagulation factor ix human | coagulation factor ix (human) | coagulation factor ix, ii, vii and x in combination | factor ix | factor ix fraction | factor viii - von willebrand factor | factor viii, von willebrand factor drug combination | human coagulation factor ix | konyne 80 | mononine | mononine | octocog alfa | pcc | plasma concentrate factor ix | profilate heat-treated | profilate hp | profilate osd | profilate sd | profilnine | profilnine sd | replenine

Organizations (16)

Research & Development (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (1)


 

Hemophilia B

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Hemophilia A (Phase 4)

Hemophilia B (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial Organizations: 15

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue